Showing results (91-100 of 120) with videos related to
Sort By:
Pageof 12
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 20, 2022
Transcription of cytochrome P450 46A1 in NIH3T3 cells is negatively regulated by FBSYasutake Shinohara, Hiromi Ando, Masamitsu Maekawa, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 12, 2024
Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving MetforminYasutake Shinohara, Teruo Jojima, Yusuke Kamiga, et al.Diabetes, Obesity & Metabolism|September 5, 2018
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver diseaseMasanori Shimizu, Kunihiro Suzuki, Kanako Kato, et al.Diabetes Research and Clinical Practice|October 5, 2010
Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetesYoshimasa Aso, Kohzo Takebayashi, Sadao Wakabayashi, et al.Internal Medicine (Tokyo, Japan)|April 8, 2026
Alcoholic Ketoacidosis Accompanied by Acute Gastric Dilation in a Patient with type 2 Diabetes on an SGLT2 Inhibitor and Chronic Alcoholic AbuseMasahiro Saito, Hidetaka Kurai, Kanako Suda, et al.Metabolism: Clinical and Experimental|July 14, 2009
Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitusNoriyuki Ozeki, Kenji Hara, Chikako Yatsuka, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|December 14, 2011
Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylureaYoshimasa Aso, Noriyuki Ozeki, Tomoko Terasawa, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|September 3, 2013
The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymesYoshimasa Aso, Tomoko Terasawa, Kanako Kato, et al.Journal of Diabetes and Its Complications|November 30, 2023
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitorSho Wakamatsu, Teruo Jojima, Masaaki Hashiguchi, et al.International Journal of Cardiology. Heart & Vasculature|June 27, 2022
Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetesTeruo Jojima, Hidetaka Kurai, Dai Tanuma, et al.Pageof 12